Once-Weekly Insulin Better Than Daily in Type 2 Diabetes
Once-weekly insulin icodec reduced A1c levels the same or better than once-daily glargine and degludec.
Stay updated with breaking news from Linical Studies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Once-weekly insulin icodec reduced A1c levels the same or better than once-daily glargine and degludec.
Vienna researchers reported that 7 of 10 patients treated with systemic sirolimus had noted improvements in skin lesions, which continued for up to 2 years of follow-up.
The World Health Organization (WHO) on Monday warned that global shortages last year of popular diabetes medicines that are also used for weight loss, such as Novo Nordisk's...
"Manni" Mohyuddin, MD, reflects on patient needs, compassionate care, medical education, and recent advances in treating multiple myeloma.
Exblifep is as effective as piperacillin-tazobactam in the treatment of complicated urinary tract infections, the European Medicines Agency said.